X4 Pharmaceuticals issues options for 80,000 shares under 2019 inducement plan
XFOR•X4 Pharmaceuticals issued options for 80,000 shares to new employees under its 2019 inducement plan. The options have a 10-year term, a $2.90 exercise price and four-year vesting, contingent on continued employment.
1. Option terms
X4 Pharmaceuticals issued inducement stock options for 80,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. The options have a 10-year term and an exercise price of $2.90 per share, set at the Sept. 30, 2026 closing price. They vest 25% after 12 months and monthly over the next 36 months, contingent on continued employment.
